guest ::
| Home > Publications database > Lipid droplets and ferritin heavy chain: a devilish liaison in human cancer cell radioresistance. > print |
| Home > Publications database > Lipid droplets and ferritin heavy chain: a devilish liaison in human cancer cell radioresistance. > print |
| 001 | 170556 | ||
| 005 | 20240229133717.0 | ||
| 024 | 7 | _ | |a 10.7554/eLife.72943 |2 doi |
| 024 | 7 | _ | |a pmid:34499029 |2 pmid |
| 024 | 7 | _ | |a altmetric:113193901 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2021-02007 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 600 |
| 100 | 1 | _ | |a Tirinato, Luca |0 P:(DE-He78)62f71d68e658453766d3f349b2b718d4 |b 0 |e First author |u dkfz |
| 245 | _ | _ | |a Lipid droplets and ferritin heavy chain: a devilish liaison in human cancer cell radioresistance. |
| 260 | _ | _ | |a Cambridge |c 2021 |b eLife Sciences Publications |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1631698572_10895 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a #EA:E041#LA:E041# |
| 520 | _ | _ | |a Although much progress has been made in cancer treatment, the molecular mechanisms underlying cancer radioresistance (RR) as well as the biological signatures of radioresistant cancer cells still need to be clarified. In this regard, we discovered that breast, bladder, lung, neuroglioma and prostate 6 Gy X-ray resistant cancer cells were characterized by an increase of Lipid Droplet (LD) number and that the cells containing highest LDs showed the highest clonogenic potential after irradiation. Moreover, we observed that LD content was tightly connected with the iron metabolism and in particular with the presence of the ferritin heavy chain (FTH1). In fact, breast and lung cancer cells silenced for the FTH1 gene showed a reduction in the LD numbers and, by consequence, became radiosensitive. FTH1 overexpression as well as iron-chelating treatment by Deferoxamine were able to restore the LD amount and RR. Overall, these results provide evidence of a novel mechanism behind RR in which LDs and FTH1 are tightly connected to each other, a synergistic effect which might be worth deeply investigating in order to make cancer cells more radiosensitive and improve the efficacy of radiation treatments. |
| 536 | _ | _ | |a 315 - Bildgebung und Radioonkologie (POF4-315) |0 G:(DE-HGF)POF4-315 |c POF4-315 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de |
| 650 | _ | 7 | |a cancer biology |2 Other |
| 650 | _ | 7 | |a human |2 Other |
| 700 | 1 | _ | |a Marafioti, Maria Grazia |0 P:(DE-He78)7d52a11d422cd6c34bd3001fe0cd3997 |b 1 |e First author |
| 700 | 1 | _ | |a Pagliari, Francesca |0 P:(DE-He78)d06e5bb2d0828caa2be79a51825e84e1 |b 2 |e First author |
| 700 | 1 | _ | |a Jansen, Jeannette |0 P:(DE-He78)02e29e2d540ff21d777f3a03ec9f5ade |b 3 |
| 700 | 1 | _ | |a Aversa, Ilenia |0 P:(DE-He78)311c5712bcd4b31083be7845ef5ea377 |b 4 |
| 700 | 1 | _ | |a Hanley, Rachel |0 P:(DE-He78)15d0e694db442a1762a025b802a56f75 |b 5 |
| 700 | 1 | _ | |a Nisticò, Clelia |0 P:(DE-He78)f9957338cc0970c985bc19ded506b7c1 |b 6 |u dkfz |
| 700 | 1 | _ | |a Garcia-Calderón, Daniel |0 P:(DE-HGF)0 |b 7 |
| 700 | 1 | _ | |a Genard, Geraldine |0 P:(DE-He78)036b60c419272e509b5b5db5246c13bc |b 8 |
| 700 | 1 | _ | |a Guerreiro, Joana Filipa |0 0000-0003-1960-603X |b 9 |
| 700 | 1 | _ | |a Costanzo, Francesco Saverio |b 10 |
| 700 | 1 | _ | |a Seco, Joao |0 P:(DE-He78)102624aca75cfe987c05343d5fdcf2fe |b 11 |e Last author |
| 773 | _ | _ | |a 10.7554/eLife.72943 |g Vol. 10, p. e72943 |0 PERI:(DE-600)2687154-3 |p e72943 |t eLife |v 10 |y 2021 |x 2050-084X |
| 909 | C | O | |o oai:inrepo02.dkfz.de:170556 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)62f71d68e658453766d3f349b2b718d4 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)7d52a11d422cd6c34bd3001fe0cd3997 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)d06e5bb2d0828caa2be79a51825e84e1 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)02e29e2d540ff21d777f3a03ec9f5ade |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)311c5712bcd4b31083be7845ef5ea377 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)15d0e694db442a1762a025b802a56f75 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)f9957338cc0970c985bc19ded506b7c1 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)036b60c419272e509b5b5db5246c13bc |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 11 |6 P:(DE-He78)102624aca75cfe987c05343d5fdcf2fe |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-315 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Bildgebung und Radioonkologie |x 0 |
| 914 | 1 | _ | |y 2021 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b ELIFE : 2019 |d 2021-02-03 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2021-02-03 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2021-02-03 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2021-02-03 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2021-02-03 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2021-02-03 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Peer review |d 2021-02-03 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |d 2021-02-03 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2021-02-03 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2021-02-03 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2021-02-03 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-02-03 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2021-02-03 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record |d 2021-02-03 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-02-03 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-02-03 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2021-02-03 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b ELIFE : 2019 |d 2021-02-03 |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2021-02-03 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2021-02-03 |
| 920 | 1 | _ | |0 I:(DE-He78)E041-20160331 |k E041 |l E041 Medizinische Physik in der Radioonkologie |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)E041-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|